
Sign up to save your podcasts
Or
A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.
4.8
2525 ratings
A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.
9,131 Listeners
91 Listeners
32,283 Listeners
43,483 Listeners
6,670 Listeners
86,708 Listeners
4 Listeners
0 Listeners
32 Listeners
9,593 Listeners
7,928 Listeners
38,676 Listeners
28,304 Listeners
15,237 Listeners
41,435 Listeners
10,556 Listeners
6 Listeners
5,290 Listeners
1,089 Listeners